212 related articles for article (PubMed ID: 18437912)
1. Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
He XR; Wu XP
Chin Med Sci J; 2008 Mar; 23(1):54-9. PubMed ID: 18437912
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
Tang X; Zhang J; Chen Y; Lan Z; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
[TBL] [Abstract][Full Text] [Related]
4. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
5. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.
Hou YJ; Dong LW; Tan YX; Yang GZ; Pan YF; Li Z; Tang L; Wang M; Wang Q; Wang HY
Lab Invest; 2011 Aug; 91(8):1146-57. PubMed ID: 21647092
[TBL] [Abstract][Full Text] [Related]
8. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
9. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
10. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.
Rattanasinganchan P; Leelawat K; Treepongkaruna SA; Tocharoentanaphol C; Subwongcharoen S; Suthiphongchai T; Tohtong R
World J Gastroenterol; 2006 Oct; 12(40):6500-6. PubMed ID: 17072981
[TBL] [Abstract][Full Text] [Related]
12. Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma.
Jensen LH; Jakobsen A
Expert Rev Anticancer Ther; 2011 Apr; 11(4):589-600. PubMed ID: 21504326
[TBL] [Abstract][Full Text] [Related]
13. First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2.
Jiang NZ; Bai MZ; Huang CF; Ma ZL; Zhong RY; Fu WK; Gao L; Tian L; Mi NN; Ma HD; Lu YW; Zhang ZA; Zhao JY; Yu HY; Zhang BP; Zhang XZ; Ren YX; Zhang C; Zhang Y; Yue P; Lin YY; Meng WB
World J Gastroenterol; 2023 Nov; 29(41):5683-5698. PubMed ID: 38077157
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
Yang B; House MG; Guo M; Herman JG; Clark DP
Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.
Blechacz B; Gores GJ
J Hepatol; 2008 Aug; 49(2):160-2. PubMed ID: 18538440
[No Abstract] [Full Text] [Related]
16. Highlights of topic "Biochemical and molecular pathological aspects of cholangiocarcinoma".
Murakami Y
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):359-61. PubMed ID: 24840727
[No Abstract] [Full Text] [Related]
17. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma with sarcomatous change producing granulocyte-colony stimulating factor.
Takenaka M; Akiba J; Kawaguchi T; Niizeki T; Arinaga-Hino T; Sata M; Nakashima O; Yano H; Kage M
Pathol Int; 2013 Apr; 63(4):233-5. PubMed ID: 23692426
[No Abstract] [Full Text] [Related]
19. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.
Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X
Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
Cavalloni G; Peraldo-Neia C; Varamo C; Casorzo L; Dell'Aglio C; Bernabei P; Chiorino G; Aglietta M; Leone F
Tumour Biol; 2016 Mar; 37(3):4041-52. PubMed ID: 26486326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
